Vanguard Group’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $647K | Buy |
397,056
+20,228
| +5% | +$29.2K | ﹤0.01% | 3887 |
|
|
2025
Q3 | $399K | Sell |
376,828
-2,173
| -0.6% | -$2.44K | ﹤0.01% | 4000 |
|
|
2025
Q2 | $440K | Sell |
379,001
-2,941
| -0.8% | -$3.56K | ﹤0.01% | 3947 |
|
|
2025
Q1 | $353K | Sell |
381,942
-5,640
| -1% | -$5.62K | ﹤0.01% | 3964 |
|
|
2024
Q4 | $333K | Hold |
387,582
| – | – | ﹤0.01% | 4031 |
|
|
2024
Q3 | $643K | Hold |
387,582
| – | – | ﹤0.01% | 3908 |
|
|
2024
Q2 | $624K | Hold |
387,582
| – | – | ﹤0.01% | 3933 |
|
|
2024
Q1 | $888K | Hold |
387,582
| – | – | ﹤0.01% | 3855 |
|
|
2023
Q4 | $872K | Buy |
387,582
+2,334
| +0.6% | +$5.63K | ﹤0.01% | 3876 |
|
|
2023
Q3 | $1.16M | Hold |
385,248
| – | – | ﹤0.01% | 3780 |
|
|
2023
Q2 | $1.59M | Hold |
385,248
| – | – | ﹤0.01% | 3739 |
|
|
2023
Q1 | $1.44M | Hold |
385,248
| – | – | ﹤0.01% | 3790 |
|
|
2022
Q4 | $2.15M | Buy |
385,248
+124,837
| +48% | +$735K | ﹤0.01% | 3630 |
|
|
2022
Q3 | $1.73M | Sell |
260,411
-105,383
| -29% | -$853K | ﹤0.01% | 3802 |
|
|
2022
Q2 | $3.64M | Buy |
365,794
+16,830
| +5% | +$161K | ﹤0.01% | 3535 |
|
|
2022
Q1 | $6.63M | Sell |
348,964
-53,624
| -13% | -$843K | ﹤0.01% | 3376 |
|
|
2021
Q4 | $7.16M | Buy |
402,588
+24,372
| +6% | +$730K | ﹤0.01% | 3415 |
|
|
2021
Q3 | $14M | Buy |
378,216
+5,992
| +2% | +$266K | ﹤0.01% | 3057 |
|
|
2021
Q2 | $22.1M | Buy |
372,224
+10,397
| +3% | +$630K | ﹤0.01% | 2784 |
|
|
2021
Q1 | $24.2M | Buy |
361,827
+98,514
| +37% | +$7.71M | ﹤0.01% | 2684 |
|
|
2020
Q4 | $15.9M | Buy |
263,313
+7,859
| +3% | +$537K | ﹤0.01% | 2749 |
|
|
2020
Q3 | $20.2M | Buy |
255,454
+4,067
| +2% | +$324K | ﹤0.01% | 2456 |
|
|
2020
Q2 | $15.7M | Sell |
251,387
-88,412
| -26% | -$5.15M | ﹤0.01% | 2543 |
|
|
2020
Q1 | $18M | Buy |
339,799
+7,894
| +2% | +$783K | ﹤0.01% | 2343 |
|
|
2019
Q4 | $40.2M | Buy |
331,905
+39,512
| +14% | +$5.68M | ﹤0.01% | 2214 |
|
|
2019
Q3 | $53.1M | Buy |
292,393
+1,139
| +0.4% | +$161K | ﹤0.01% | 2035 |
|
|
2019
Q2 | $37.9M | Buy |
291,254
+15,770
| +6% | +$2.83M | ﹤0.01% | 2243 |
|
|
2019
Q1 | $67.1M | Buy |
275,484
+9,574
| +4% | +$2.53M | ﹤0.01% | 1945 |
|
|
2018
Q4 | $50.7M | Buy |
265,910
+8,029
| +3% | +$1.96M | ﹤0.01% | 2018 |
|
|
2018
Q3 | $84.6M | Buy |
257,881
+23,075
| +10% | +$7.07M | ﹤0.01% | 1885 |
|
|
2018
Q2 | $73.3M | Buy |
234,806
+6,921
| +3% | +$2.11M | ﹤0.01% | 1924 |
|
|
2018
Q1 | $55.5M | Sell |
227,885
-192
| -0.1% | -$53.9K | ﹤0.01% | 2019 |
|
|
2017
Q4 | $68.9M | Buy |
228,077
+9,874
| +5% | +$2.75M | ﹤0.01% | 1906 |
|
|
2017
Q3 | $57.7M | Buy |
218,203
+13,581
| +7% | +$3.93M | ﹤0.01% | 1968 |
|
|
2017
Q2 | $53.9M | Buy |
204,622
+8,585
| +4% | +$2.15M | ﹤0.01% | 1982 |
|
|
2017
Q1 | $70.6M | Buy |
196,037
+10,319
| +6% | +$3.19M | ﹤0.01% | 1832 |
|
|
2016
Q4 | $53.6M | Buy |
185,718
+4,290
| +2% | +$1.33M | ﹤0.01% | 1934 |
|
|
2016
Q3 | $61.8M | Buy |
181,428
+6,425
| +4% | +$2.35M | ﹤0.01% | 1835 |
|
|
2016
Q2 | $74.4M | Buy |
175,003
+59,887
| +52% | +$24.7M | ﹤0.01% | 1701 |
|
|
2016
Q1 | $36.8M | Buy |
115,116
+13,535
| +13% | +$4.62M | ﹤0.01% | 2002 |
|
|
2015
Q4 | $52.7M | Buy |
101,581
+5,882
| +6% | +$2.17M | ﹤0.01% | 1860 |
|
|
2015
Q3 | $28M | Buy |
95,699
+16,003
| +20% | +$5.69M | ﹤0.01% | 2134 |
|
|
2015
Q2 | $31.3M | Buy |
79,696
+3,533
| +5% | +$1.25M | ﹤0.01% | 2161 |
|
|
2015
Q1 | $23M | Buy |
76,163
+9,116
| +14% | +$2.23M | ﹤0.01% | 2266 |
|
|
2014
Q4 | $14.9M | Buy |
67,047
+5,192
| +8% | +$1.07M | ﹤0.01% | 2374 |
|
|
2014
Q3 | $14.3M | Buy |
61,855
+5,576
| +10% | +$1.4M | ﹤0.01% | 2339 |
|
|
2014
Q2 | $12.4M | Buy |
56,279
+3,095
| +6% | +$689K | ﹤0.01% | 2411 |
|
|
2014
Q1 | $16.8M | Buy |
53,184
+12,915
| +32% | +$4.11M | ﹤0.01% | 2254 |
|
|
2013
Q4 | $10.5M | Buy |
40,269
+17,714
| +79% | +$3.88M | ﹤0.01% | 2439 |
|
|
2013
Q3 | $3.3M | Buy |
22,555
+1,587
| +8% | +$192K | ﹤0.01% | 2935 |
|
|
2013
Q2 | $3.18M | Buy |
+20,968
| New | +$2.87M | ﹤0.01% | 2900 |
|
Other funds holding TXMD
RCMNY
CC
TC
ACM
Vanguard Group's TXMD Position: Q4 2025 in Review
Vanguard Group increased its TherapeuticsMD (TXMD) stake by 5.4% in Q4 2025, buying an estimated $29.2K and bringing the position to 397,056 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #3887.
Vanguard Group first reported a position in TXMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $84.6M in Q3 2018. 44 funds tracked by Wall St. Rank hold TXMD as of Q4 2025.
- Vanguard Group held 397,056 shares of TherapeuticsMD worth $647K as of Q4 2025.
- Vanguard Group bought 20,228 TherapeuticsMD shares in Q4 2025, an estimated $29.2K.
- TherapeuticsMD made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3887 holding.
- Vanguard Group first reported a position in TherapeuticsMD in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's TherapeuticsMD position peaked at $84.6M in Q3 2018.
- 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.